GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $52.00 $59.03 Friday, 19th Apr 2024 INCY stock ended at $52.35. This is 0.89% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 1.92% from a day low at $52.00 to a day high of $53.00.
90 days $52.00 $62.19
52 weeks $50.27 $75.74

Historical Incyte Corporation prices

Date Open High Low Close Volume
2024-04-19 $52.97 $53.00 $52.00 $52.35 1 880 287
2024-04-18 $52.96 $53.10 $52.26 $52.82 1 787 018
2024-04-17 $53.22 $53.78 $52.70 $52.72 2 454 796
2024-04-16 $53.34 $54.09 $53.15 $53.22 1 430 120
2024-04-15 $53.91 $54.30 $53.41 $53.43 1 534 404
2024-04-12 $54.72 $55.00 $53.76 $53.85 1 172 995
2024-04-11 $55.34 $55.99 $54.63 $54.92 1 559 176
2024-04-10 $54.85 $55.25 $54.47 $55.00 1 022 836
2024-04-09 $55.20 $56.46 $55.19 $55.30 1 481 644
2024-04-08 $54.97 $55.42 $54.42 $55.05 1 210 758
2024-04-05 $54.84 $55.41 $54.26 $55.24 1 576 500
2024-04-04 $55.55 $55.86 $54.83 $54.99 1 449 570
2024-04-03 $55.84 $56.21 $55.00 $55.31 1 855 772
2024-04-02 $56.56 $57.15 $55.79 $55.83 2 008 489
2024-04-01 $56.97 $56.97 $56.03 $56.64 1 239 008
2024-03-28 $57.25 $57.33 $56.61 $56.97 1 761 651
2024-03-27 $56.52 $57.30 $56.50 $57.12 1 463 986
2024-03-26 $57.53 $57.56 $56.52 $56.55 1 610 260
2024-03-25 $57.14 $57.59 $56.57 $57.48 1 841 460
2024-03-22 $57.98 $57.98 $56.96 $56.98 1 152 421
2024-03-21 $58.57 $59.03 $57.47 $57.72 1 503 966
2024-03-20 $58.03 $58.41 $57.50 $58.24 1 698 646
2024-03-19 $57.70 $58.44 $57.18 $58.33 2 428 899
2024-03-18 $58.75 $58.75 $57.30 $57.34 1 785 973
2024-03-15 $58.30 $58.76 $57.53 $58.37 3 589 431
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT